1. Home
  2. JAGX vs ISPC Comparison

JAGX vs ISPC Comparison

Compare JAGX & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • ISPC
  • Stock Information
  • Founded
  • JAGX 2013
  • ISPC 2009
  • Country
  • JAGX United States
  • ISPC United States
  • Employees
  • JAGX N/A
  • ISPC N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • ISPC Precision Instruments
  • Sector
  • JAGX Health Care
  • ISPC Health Care
  • Exchange
  • JAGX Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • JAGX 3.5M
  • ISPC 3.1M
  • IPO Year
  • JAGX N/A
  • ISPC 2021
  • Fundamental
  • Price
  • JAGX $2.58
  • ISPC $0.94
  • Analyst Decision
  • JAGX Strong Buy
  • ISPC
  • Analyst Count
  • JAGX 1
  • ISPC 0
  • Target Price
  • JAGX $60.00
  • ISPC N/A
  • AVG Volume (30 Days)
  • JAGX 90.6K
  • ISPC 51.4K
  • Earning Date
  • JAGX 08-12-2025
  • ISPC 08-05-2025
  • Dividend Yield
  • JAGX N/A
  • ISPC N/A
  • EPS Growth
  • JAGX N/A
  • ISPC N/A
  • EPS
  • JAGX N/A
  • ISPC N/A
  • Revenue
  • JAGX $11,552,000.00
  • ISPC $8,058,631.00
  • Revenue This Year
  • JAGX $22.41
  • ISPC $35.93
  • Revenue Next Year
  • JAGX $30.00
  • ISPC N/A
  • P/E Ratio
  • JAGX N/A
  • ISPC N/A
  • Revenue Growth
  • JAGX 13.93
  • ISPC N/A
  • 52 Week Low
  • JAGX $2.43
  • ISPC $0.86
  • 52 Week High
  • JAGX $110.75
  • ISPC $11.80
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 28.76
  • ISPC 37.62
  • Support Level
  • JAGX $2.61
  • ISPC $0.86
  • Resistance Level
  • JAGX $3.30
  • ISPC $0.97
  • Average True Range (ATR)
  • JAGX 0.28
  • ISPC 0.06
  • MACD
  • JAGX 0.06
  • ISPC -0.02
  • Stochastic Oscillator
  • JAGX 6.56
  • ISPC 18.79

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: